Funding for this research was provided by:
National Institutes of Health (2RO1-HL64726)
Received: 7 March 2017
Accepted: 1 August 2017
First Online: 11 August 2017
Ethics approval and consent to participate
: Institutional Review Board approval was received at each center, and all patients gave written informed consent.
: Not applicable.
: Dr. Heiberg is the founder of Medviso AB (Segment Software; Lund, Sweden). Dr. Arheden is the founder of Imacor AB (Lund, Sweden). Kim is an inventor on a US patent on Delayed-enhancement CMR, which is owned by Northwestern University. None of the other investigators have potential conflicts to report.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.